Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. The Company owns more than 16 brands of products which are distributed mainly in the healthcare practitioner and health food and specialized store channels in more than 35 countries, with a primary focus in North America and Europe. The Company manufactures and markets more than 2,000 health and nutrition finished products. The products are generated primarily from natural sources and include vitamins, minerals and specialized products such as enzymes, probiotics and omega-3. In October 2013, the Company announced that it has acquired 70% interest of Mucos Pharma CZ s.r.o. In February 2014, Atrium Innovations Inc announced the completion of the acquisition of Atrium by corporations backed by the Permirafunds.
Industry, Sector and Symbol
Stock Exchange TSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolTSE:ATB
Previous Symbol
CUSIPN/A
Phone+1-514-2056240
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market CapC$0.00
OptionableNot Optionable
Atrium Innovations (TSE:ATB) Frequently Asked Questions
What is Atrium Innovations' stock symbol?
Atrium Innovations trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ATB."
Has Atrium Innovations been receiving favorable news coverage?
Media coverage about ATB stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Atrium Innovations earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term.
How do I buy shares of Atrium Innovations?
Shares of ATB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Atrium Innovations' official website?
How can I contact Atrium Innovations?
Atrium Innovations' mailing address is 3500 de Maisonneuve Blvd W Suite 2405, WESTMOUNT, QC H3Z 3C1, Canada. The company can be reached via phone at +1-514-2056240.
MarketBeat Community Rating for Atrium Innovations (TSE ATB)
MarketBeat's community ratings are surveys of what our community members think about Atrium Innovations and other stocks. Vote "Outperform" if you believe ATB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATB will underperform the S&P 500 over the long term. You may vote once every thirty days.
